Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors

Figure 2

Moderate to strong PR immunostaining in “nonmammary” and “nongynecological” tumors. (a) Neuroendocrine tumor of the pancreas. (b) Neuroendocrine carcinoma of the pancreas. (c) Small cell carcinoma of the lung. (d) Leydig cell tumor of the testis. (e) Medullary thyroid carcinoma. (f) Follicular thyroid carcinoma. (g) Papillary thyroid carcinoma. (h) Angiomyolipoma.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)